Table 3.
DFS | OS | |||
---|---|---|---|---|
Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | |
Univariate analysis | ||||
CELSR3 mRNA | 1.292(1.077-1.550) | 0.006 | 1.785(1.341-2.376) | <0.001 |
Gleason score | 2.190(1.763-2.721) | <0.001 | 2.973(1.342-6.585) | 0.007 |
PSA | 1.048(1.017-1.080) | 0.002 | 1.062(1.004-1.124) | 0.036 |
Pathological stage | 2.615(1.733-3.945) | <0.001 | 2.245(0.600-8.403) | 0.230 |
Age | 1.027(0.995-1.060) | 0.095 | 1.053(0.956-1.161) | 0.294 |
Multivariate analysis | ||||
CELSR3 mRNA | 1.143(0.571-2.288) | 0.614 | 4.591(1.584-13.309) | 0.835 |
Gleason score | 1.944(1.533-2.465) | <0.001 | 2.361(1.104-5.049) | 0.027 |
PSA | 1.043(0.980-1.110) | 0.155 | 1.005(1.001-1.009) | 0.212 |
Pathological stage | 1.702(1.043-2.778) | 0.033 | 2.198(1.281-3.770) | 0.987 |
Age | 1.053(0.938-1.181) | 0.705 | 1.024(0.974-1.077) | 0.438 |